Drug survival of infliximab and adalimumab in inflammatory bowel disease.

Erfan Asadipour Mona Kargar

Published in: International journal of clinical pharmacy (2020)

Keyphrases

ulcerative colitis
rheumatoid arthritis
juvenile idiopathic arthritis
free survival
hidradenitis suppurativa
drug induced
emergency department
systemic lupus erythematosus
disease activity